Graph Therapeutics
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
$5MSeries A
Role not disclosedMC
Merantix Capital
Activity from announced rounds
Activity in this selectionBiotech
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $8.5M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionOutpost Bio
Develops AI-driven models to decode human microbiology
$3.5MPre-Seed
Role not disclosed